Waltham, MA MAY 6, 2021 – Trinity Life Sciences, a leader in global life science commercialization solutions, announced the winners of the TGaS Best of Benchmark (BoBs) Awards. The Awards, which are given for commercial operations excellence within the pharmaceutical industry, were presented to teams at AbbVie, Biogen, Genentech, Lundbeck, Otsuka, Pharmacyclics and Janssen Biotech, Inc. The BoBs are based on TGaS benchmarking of large, midsize, and emerging life sciences companies.
While the specific BoB criteria subtly changes from function to function, the underlying factor for recognition is a commercial operations pharma team that demonstrates the best capability relative to peers in the industry for a specific department, function, or process. Winners are chosen based on TGaS benchmarks and other benchmark-based project work that gives the TGaS Division a deep understanding of all eligible clients.
“We couldn’t be more excited to recognize this year’s deserving winners at our Best of Benchmark Awards ceremony,” said Gary McWalters, President, TGaS Advisors, a division of Trinity. “The winning companies and their operational leaders faced unprecedented challenges in 2020 due to the COVID pandemic yet rose to the occasion by implementing best-in-class solutions and capabilities that set them apart from their peer group.”
Fourth Annual Best of Benchmark Award Winners:
- Commercial Analytics and Insights: Forecasting – Genentech
- Field Operations: Field Operations Management – Lundbeck
- Learning and Development: Metrics and Management – Otsuka
- Marketing Operations: External Agency Management – Biogen
- Medical/Regulatory/Legal: MRL Process, Technology and Training – AbbVie
- Omnichannel Marketing: Consumer Display Campaign – Pharmacyclics
- Omnichannel Marketing: Consumer Display Campaign – Janssen Biotech, Inc.
- Omnichannel Marketing:Digital Analytics Capabilities – Biogen
“Congratulations to all the winners, it is an honor to work with people who emphasize excellence,” continued Mr. McWalters.
About TGaS® Advisors
TGaS Advisors, a division of Trinity Life Sciences, is the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. With a roster of large, emerging and precommercial life sciences companies, TGaS provides robust comparative intelligence and collaborative network membership services. The team includes more than 50 experienced professionals, most with senior-level experience in the life sciences and related industries. To learn more about how TGaS is driving commercial excellence in the biopharmaceutical industry, visit www.tgas.com
About Trinity Life SciencesTrinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.